Document Detail

The onset time of atracurium is prolonged in patients with sickle cell disease.
MedLine Citation:
PMID:  18635475     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Patients with sickle cell disease (SCD) frequently undergo surgery during their lifetime. Patients with SCD are considered at greater risk of perioperative complications than otherwise healthy patients and require meticulous anesthetic management. The pharmacodynamics of anesthetics may be altered in patients with SCD due to microcirculatory abnormalities or anemia. METHODS: In this study, we assessed the pharmacodynamics of a single dose of atracurium (0.5 mg/kg) by mechanomyography in 13 patients with SCD and in 17 control patients. RESULTS: The time between atracurium administration and 90% twitch height depression (onset time) was longer in SCD patients (mean +/- sd) 323 +/- 124 s than in controls 165 +/- 36 s (P < 0.01). Unsatisfactory intubation conditions at 3 min after atracurium administration were observed in 5/13 patients with SCD and 1/17 control patients (P < 0.05). The duration of action of atracurium in patients with SCD was similar to that of control patients. The time to spontaneous return of the train-of-four ratio to 0.9 was 101 +/- 24 min in control patients and did not differ 93 +/- 24 min in patients with SCD. CONCLUSION: Delayed onset time, together with unchanged duration of the neuromuscular blocking effect of atracurium, may be explained by an increased distribution volume of atracurium in patients with SCD. Our results suggest that monitoring of neuromuscular block may guide the time of tracheal intubation in patients with SCD.
Philippe Dulvadestin; Alain Gilton; Philippe Hernigou; Jean Marty
Related Documents :
2802385 - Splenectomy and the sick asplenic patient.
8042135 - Preanesthesia transfusion and sickle cell anemia patients: case report and controversies.
10849385 - Alloimmunization in chinese with warm autoimmune haemolytic anaemia - incidence and cha...
22892485 - Effectiveness of lanthanum carbonate treatment used in combination with other phosphate...
20138655 - Utility of urine cytology in the workup of asymptomatic microscopic hematuria in low-ri...
19454405 - Repair of joint erosions in rheumatoid arthritis: prevalence and patient characteristic...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anesthesia and analgesia     Volume:  107     ISSN:  1526-7598     ISO Abbreviation:  Anesth. Analg.     Publication Date:  2008 Jul 
Date Detail:
Created Date:  2008-07-18     Completed Date:  2008-08-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1310650     Medline TA:  Anesth Analg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  113-6     Citation Subset:  AIM; IM    
Department of Anesthesia and Intensive Care, Hopital Henri Mondor, Assistance Publique Hôpitaux de Paris, Université Paris, Créteil, France. philippe.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anemia, Sickle Cell / physiopathology*
Atracurium / pharmacology*
Middle Aged
Neuromuscular Blockade
Neuromuscular Nondepolarizing Agents / pharmacology*
Time Factors
Reg. No./Substance:
0/Neuromuscular Nondepolarizing Agents; 64228-79-1/Atracurium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors.
Next Document:  Variability comparison of the composite auditory evoked potential index and the bispectral index dur...